BACKGROUND: Charcot Marie Tooth type 1a (CMT1a) is a primarily demyelinating neuropathy, characterized by slowly progressive muscle weakness, atrophy, and sensory loss, and is most pronounced in both feet and hands. There is increasing evidence that muscle weakness is determined by motor axonal dysfunction. OBJECTIVE: To investigate in patients with CMT1a whether motor axon loss, as estimated with motor unit number estimation (MUNE) and compound muscle action potential (CMAP), is related to hand function and manual dexterity. METHODS: Hand function, manual dexterity, and axon loss were studied in 48 patients with proven CMT1a. Using high-density surface EMG on the thenar muscles, MUNE was determined and CMAPs were measured. RESULTS: Pinch s...
Background In overwork weakness (OW), muscles are increasingly weakened by exercise, work or daily a...
Hand strength, function and disease-related symptoms were determined in 84 children, aged 2-16 years...
This study evaluates primary and secondary clinical outcome measures in Charcot-Marie-Tooth disease ...
Contains fulltext : 70597.pdf (publisher's version ) (Closed access)BACKGROUND: Ch...
BACKGROUND: Clinical features of Charcot-Marie-Tooth disease type 1A (CMT1A) include slowly progress...
There have been suggestions from previous studies that patients with Charcot-Marie-Tooth disease (CM...
AbstractThere have been suggestions from previous studies that patients with Charcot–Marie–Tooth dis...
Charcot-Marie-Tooth disease type 1A (CMT1A), a demyelinating neuropathy characterised by progressive...
BACKGROUND: Charcot-Marie-Tooth disease type 1A (CMT1A) is known as a demyelinating hereditary neuro...
Background: Charcot-Marie-Tooth disease type 1A (CMT1A) is known as a demyelinating hereditary neuro...
There have been suggestions from previous studies that patients with Charcot-Marie-Tooth disease (CM...
International audiencePeripheral neuropathies are subdivided into acquired and hereditary transmitte...
In this study, the intra- and interobserver reliability of the Semmes-Weinstein monofilaments (SWMFs...
INTRODUCTION: Nerve cross sectional area (CSA) is larger than normal in Charcot-Marie-Tooth disease ...
Objective: The aim of this study was to assess the usefulness of motor unit number index (MUNIX) tec...
Background In overwork weakness (OW), muscles are increasingly weakened by exercise, work or daily a...
Hand strength, function and disease-related symptoms were determined in 84 children, aged 2-16 years...
This study evaluates primary and secondary clinical outcome measures in Charcot-Marie-Tooth disease ...
Contains fulltext : 70597.pdf (publisher's version ) (Closed access)BACKGROUND: Ch...
BACKGROUND: Clinical features of Charcot-Marie-Tooth disease type 1A (CMT1A) include slowly progress...
There have been suggestions from previous studies that patients with Charcot-Marie-Tooth disease (CM...
AbstractThere have been suggestions from previous studies that patients with Charcot–Marie–Tooth dis...
Charcot-Marie-Tooth disease type 1A (CMT1A), a demyelinating neuropathy characterised by progressive...
BACKGROUND: Charcot-Marie-Tooth disease type 1A (CMT1A) is known as a demyelinating hereditary neuro...
Background: Charcot-Marie-Tooth disease type 1A (CMT1A) is known as a demyelinating hereditary neuro...
There have been suggestions from previous studies that patients with Charcot-Marie-Tooth disease (CM...
International audiencePeripheral neuropathies are subdivided into acquired and hereditary transmitte...
In this study, the intra- and interobserver reliability of the Semmes-Weinstein monofilaments (SWMFs...
INTRODUCTION: Nerve cross sectional area (CSA) is larger than normal in Charcot-Marie-Tooth disease ...
Objective: The aim of this study was to assess the usefulness of motor unit number index (MUNIX) tec...
Background In overwork weakness (OW), muscles are increasingly weakened by exercise, work or daily a...
Hand strength, function and disease-related symptoms were determined in 84 children, aged 2-16 years...
This study evaluates primary and secondary clinical outcome measures in Charcot-Marie-Tooth disease ...